Urgent relief for migraine attacks – «Amigren»
Migraine is a chronic condition affecting millions of people worldwide, causing periodic episodes of moderate-to-severe headache. However, the limited understanding of the mechanisms behind migraine and available treatment options has led to the development of myths. We are going to debunk the most common ones.*
Myth 1: Migraine is a mental disorder.
Reality: While there certainly is a link between migraines and mental health, migraine itself is not a mental illness. It is a neurological condition that requires a unique set of preventive and emergency treatment.
Myth 2: It is normal «getting over» a migraine attack without taking medication.
Reality: Frequent use of medication to relieve headache is a major concern for those who often suffer from migraine symptoms. However, insufficient treatment of migraine attacks can actually worsen the symptoms and lead to more severe issues in the future.
Myth 3: If you do not treat a migraine immediately, there is no point in treating it later.
Reality: While the best time to treat a migraine attack is an early phase, when the headache is mild, most treatment options will still be effective even in the later stages of the attack.
To assist Ukrainians suffering from migraine attacks, the pharmaceutical company «Astrapharm» supplies the Ukrainian market with a medication containing sumatriptan «Amigren».
By constricting blood vessels in the carotid arterial system and inhibiting trigeminal nerve activity, «Amigren» alleviates headache, reduces nausea, vomiting, and sensitivity to light and sound, thereby improving patients’ overall condition.
«Amigren» is available in capsule form containing 50 or 100 mg of sumatriptan, with 3 or 10 capsules per blister.
The clinical effect is observed within 30 minutes after oral administration of the medication.
The drug is dispensed on prescription only.
Astrapharm – the art of helping people!
Share: